InVivo Therapeutics Holdings Corp (NVIVQ)

[BioBull1]

Hound, the clinical trial site has stated June 2017 for nearly two years, however, it is meaningless as it would require Invivo to enroll 11 eligible patients in the next month in order to assess them all at the six month endpoint.

On another note, I've asked before but never received any feedback; why did the 10-Q's filed by this company suddenly call out INSPIRE as a 30 patient trial? Another fumble of poor communication from the BOD?